Your search returned 22 studies. (Get alerts for new studies):
- A Phase I Study of WT1 Peptides to Induce Anti-Leukemia Immune Responses Following Autologous or Allogeneic Transplantation for AML, CML, ALL, MDS, an
Conditions: Acute Myelogenous Leukemia (AML) - Chronic Myelogenous Leukemia (CML) - Acute Lymphoblastic Leukemia (ALL) - Myelodysplastic Syndrome (MDS) - B Cell Malignancies
1 Location available
- A Pharmacokinetic (PK) Study of Nilotinib in Pediatric Patients With Philadelphia Chromosome-positive (Ph+) Chronic Myelogenous Leukemia (CML) or Acut
Conditions: Chronic Myeloid Leukemia - Acute Lymphoblastic Leukemia
1 Location available
- CMR Rate of Newly Diagnosed CML-CP Patients Treated With Nilotinib
Conditions: Chronic Myelogenous Leukemia in Chronic Phase
11 Locations available
- Mismatched Family Member Donor Transplantation for Children and Young Adults With High Risk Hematological Malignancies
Conditions: Leukemia, Acute Lymphocytic (ALL) - Leukemia, Myeloid, Acute(AML) - Leukemia, Myeloid, Chronic(CML) - Juvenile Myelomonocytic Leukemia (JMML) - Hemoglobinuria, Paroxysmal Nocturnal (PNH) - Hodgkin Lymphoma - Lymphoma, Non-Hodgkin (NHL) - Myelodysplastic S
1 Location available
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
Conditions: Chronic Myeloid Leukemia
88 Locations available
- Pegasys in Patients With Chronic Myeloid Leukemia (CML)
Conditions: Leukemia
1 Location available
- Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Conditions: Chronic Myelogenous Leukemia
1 Location available
- Study of KB004 in Subjects With Hematologic Malignancies
Conditions: Acute Myeloid Leukemia (AML) - Acute Lymphocytic Leukemia (ALL) - Chronic Myelogenous Leukemia (CML) - Myelodysplastic Syndrome (MDS) - Myeloproliferative Neoplasms (MPN)
2 Locations available
- Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
Conditions: Stem Cell Transplantation - Leukemia
1 Location available
- Haploidentical Allogeneic Transplant w/Post Transplant Infusion of Regulatory T-cells (BMT Protocol 204)
Conditions: Leukemia - Leukemia Chronic Myelogenous Leukemia (CML) - Blood and Marrow Transplant (BMT) - Myelodysplastic Syndromes (MDS) - Lymphomas: Non-Hodgkin
1 Location available
- Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
Conditions: Leukemia, Acute Myelogenous (AML) - Leukemia, Acute Lymphocytic (ALL) - Leukemia, Chronic Myelogenous (CML) - Myelodysplastic Syndrome (MDS) - Non-Hodgkin's Lymphoma (NHL)
1 Location available
- Clinical Trial of L-Grb-2 Antisense Oligonucleotide in CML, AML, ALL & MDS
Conditions: Safety and Pharmacokinetics of L-Grb-2 in Treating CML, AML, CLL and MDS
1 Location available
- Telemonitoring Study - for Chronic Myeloid Leukemia (CML)
Conditions: Chronic Myeloid Leukemia
2 Locations available
- Improving Blood Stem Cell Collection and Transplant Procedures
Conditions: Myelodysplastic Syndrome (MDS) - Chronic Myelogenous Leukemia - Acute Lymphoblastic Leukemia - CML (Chronic Myelogenous Leukemia - CLL (Chronic Lymphocytic Leukemia) - Acute Myeloid Leukemia (AML)
1 Location available
- Ponatinib - Frontline for Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)
Conditions: Leukemia
1 Location available
- Phase II Nilotinib With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia (CML)
Conditions: Leukemia, Myelogenous, Chronic
1 Location available
- Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML.
Conditions: Chronic Myelogenous Leukemia
1 Location available
- Arsenic Trioxide and Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia (CML)
Conditions: Chronic Myelogenous Leukemia
1 Location available
- A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imat
Conditions: Leukemia
14 Locations available
- A Dose-Escalation and Pharmacokinetic Study of TG02 Citrate in Patients With Advanced Hematological Malignancies
Conditions: AML - ALL - CML in Blast Crisis - High-Risk MDS - Multiple Myeloma
5 Locations available
- Dasatinib and Cyclosporine in Patients With Chronic Myelogenous Leukemia (CML)
Conditions: Chronic Myelogenous Leukemia
1 Location available
- Pilot Study to Assess Telemonitoring of Gleevec (Imatinib Mesylate) or Tasigna (Niltinib) Therapy
Conditions: Chronic Phase CML
2 Locations available
|